查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1622868

噴霧器設備的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2024年～2031年)

Nebulizer Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 244 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球霧化器市場規模將達到11.208億美元，2024-2031年預測期間複合年增長率為8.5%，2031年將達到19.78億美元。

霧化器用於以霧狀形式將藥物吸入肺部，主要用於治療氣喘、慢性阻塞性肺病（COPD）和囊性纖維化等呼吸系統疾病。霧化器包括噴射霧化器、網狀霧化器和超音波霧化器，用於家庭保健和醫院環境。市場成長的主要驅動力包括呼吸系統疾病盛行率的增加、老年人口的增加以及對呼吸系統健康意識的增強。

由於多種因素，包括全球氣喘和慢性阻塞性肺病盛行率的上升，全球霧化器設備市場正在顯著成長。人口老化加劇，更容易患呼吸道疾病，進一步推動了對霧化器設備的需求。此外，便攜式和用戶友好型設備等霧化器技術的進步以及醫療保健意識的提高正在促進市場成長。向家庭醫療保健解決方案的轉變以及對非侵入性治療的日益偏好也推動了霧化器在家庭環境中的採用。

由於人們對呼吸健康的認識不斷增強以及對家庭護理解決方案的需求不斷增長，霧化器設備市場正在提供巨大的機會。小型便攜式電池供電霧化器的開發等創新提供了新的成長機會。由於環境因素和生活方式的改變，呼吸系統疾病呈上升趨勢的新興市場也存在巨大潛力。此外，擴大採用治療氣喘和慢性阻塞性肺病的聯合療法，為霧化器製造商提供了開發適合特定治療的設備的機會。

本報告提供全球噴霧器設備市場相關調查，提供各產品類型，各終端用戶，各用途，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 市場觀點

  • 宏觀因素
  • 促進因素
  • 阻礙因素
  • 趨勢
  • 機會
  • 國家展望（北美）
  • 國家展望（歐洲和亞太地區）
  • 美國慢性阻塞性肺病 (COPD) 盛行率
  • 美國氣喘盛行率
  • 偏好和見解
  • 產品市場場景
  • 產品類型的演變
  • 利潤率與利潤分析
  • 製造商
  • 用於治療氣喘和慢性阻塞性肺病的藥物
  • 救贖（北美洲）
  • 租賃產品場景（北美）
  • 保險（北美）
  • 波特五力分析
  • 主要規定

第4章 北美的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

  • 市場規模(100萬美元)的分析，2019年～2023年，各國
  • 市場規模(100萬美元)的預測，2024年～2031年，各國
  • 市場規模(100萬美元)的分析，2019年～2023年，各產品類型
  • 市場規模(100萬美元)的預測，2024年～2031年，各產品類型
  • 市場規模(100萬美元)的分析，2019年～2023年，各用途
  • 市場規模(100萬美元)的預測，2024年～2031年，各用途
  • 市場規模(100萬美元)的分析，2019年～2023年，各終端用戶
  • 市場規模(100萬美元)的預測，2024年～2031年，各終端用戶
  • 市場魅力分析
  • 主要的代表性的市場參與企業
  • 主要加入企業的市場影響(強度地圖)

第5章 南美的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第6章 西歐的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第7章 東歐的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第8章 日本以外亞太地區的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第9章 日本的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第10章 中東·非洲的噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)

第11章 預測要素:相關性及影響

第12章 預測的前提條件

第13章 競爭情形

  • 競爭儀表板
  • 企業簡介(詳細內容- 概要，財務，策略，最近的趨勢)
    • Agilent Technologies, Inc.
    • Allied Healthcare Products, Inc.
    • CareFusion Corporation (sub. Becton, Dickinson and Company)
    • Covidien plc (sub. Medtronic)
    • GE Healthcare
    • GF Health Products Inc.
    • Omron Healthcare, Inc.
    • PARI GmbH
    • Koninklijke Philips N.V.

第14章 全球噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)，各地區

  • 市場規模(100萬美元)的分析，2019年～2023年，各地區
  • 市場規模(100萬美元)的預測，2024年～2031年，各地區
  • 市場魅力分析，各地區

第15章 全球噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)，各產品類型

  • 市場規模(100萬美元)的分析，2019年～2023年，各產品類型
  • 市場規模(100萬美元)的預測，2024年～2031年，各產品類型
  • 市場魅力分析，各產品類型

第16章 全球噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)，各用途

  • 市場規模(100萬美元)的分析，2019年～2023年，各用途
  • 市場規模(100萬美元)的預測，2024年～2031年，各用途
  • 市場魅力分析，各用途

第17章 噴霧器設備市場分析(2019年～2023年)及預測(2024年～2031年)，各終端用戶

  • 市場規模(100萬美元)的分析，2019年～2023年，各終端用戶
  • 市場規模(100萬美元)的預測，2024年～2031年，各終端用戶
  • 市場魅力分析，各終端用戶

第18章 全球(2019年～2023年)及預測(2024年～2031年)

第19章 調查手法

簡介目錄
Product Code: PMRREP22411

Persistence Market Research recently unveiled an in-depth report on the global Nebulizer Devices Market, analyzing key market dynamics, including drivers, trends, opportunities, and challenges. This comprehensive research provides exclusive data and projections for the nebulizer devices market's growth trajectory from 2024 to 2031.

Key Insights:

  • Nebulizer Devices Market Size (2024E): US$ 1120.8 Million
  • Projected Market Value (2031F): US$ 1978 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Nebulizer Devices Market Overview:

Nebulizers are medical devices used to administer medication in the form of a mist inhaled into the lungs, primarily for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizer devices include jet nebulizers, mesh nebulizers, and ultrasonic nebulizers, with applications across both homecare and hospital settings. Key drivers of market growth include the increasing prevalence of respiratory diseases, the rising geriatric population, and the growing awareness about respiratory health.

Market Growth Drivers:

The global nebulizer devices market is experiencing significant growth due to several factors, including the rising incidence of asthma and COPD worldwide. The growing aging population, which is more susceptible to respiratory disorders, further fuels the demand for nebulizer devices. Additionally, advancements in nebulizer technology, such as portable and user-friendly devices, along with increasing healthcare awareness, are contributing to the growth of the market. The shift towards home healthcare solutions and the rising preference for non-invasive treatments also support the adoption of nebulizers in home settings.

Market Restraints:

Despite positive growth prospects, the nebulizer devices market faces certain challenges. One of the key barriers is the relatively high cost of nebulizers, which may limit their affordability, particularly in developing countries. Moreover, the lack of awareness in some regions about the benefits of nebulizer treatments can also hinder market adoption. Regulatory challenges, including lengthy approval processes for new devices and the need for consistent product standards, may slow down the introduction of new, innovative devices. Additionally, the maintenance and cleaning requirements of nebulizers could be a deterrent for some patients, especially in homecare settings.

Market Opportunities:

The nebulizer devices market offers significant opportunities driven by the rising awareness of respiratory health and the growing demand for homecare solutions. Technological innovations, such as the development of compact, portable, and battery-operated nebulizers, present new growth opportunities. There is also considerable potential in emerging markets, where respiratory diseases are on the rise due to environmental factors and lifestyle changes. Furthermore, the increasing adoption of combination therapies for asthma and COPD provides opportunities for nebulizer manufacturers to develop devices tailored to specific treatments.

Key Questions Addressed:

  • What are the main factors driving the global growth of the nebulizer devices market?
  • Which product types and applications are witnessing the highest adoption in the nebulizer devices market?
  • How are technological advancements shaping the competitive landscape of the nebulizer devices market?
  • Who are the leading players in the nebulizer devices market, and what strategies are they employing to maintain leadership?
  • What are the emerging trends and future prospects for the global nebulizer devices market?

Competitive Intelligence & Strategic Insights:

Major players in the global nebulizer devices market, including Philips Healthcare, Omron Healthcare, and PARI GmbH, focus on product innovation, strategic partnerships, and expanding their product portfolios to strengthen their market position. These companies invest in research and development to create more efficient, user-friendly nebulizer devices with enhanced features. Collaborations with healthcare providers, pharmaceutical companies, and homecare organizations are key strategies to expand market reach. Furthermore, raising consumer awareness through educational campaigns about the benefits of nebulizer therapy is crucial for improving market penetration and driving long-term growth.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Allied Healthcare Products, Inc.
  • CareFusion Corporation (sub. Becton, Dickinson and Company)
  • Covidien plc (sub. Medtronic)
  • GE Healthcare
  • GF Health Products Inc.
  • Omron Healthcare, Inc.
  • PARI GmbH
  • Koninklijke Philips N.V.

Nebulizer Devices Market: Segmentation

By Product Type

  • Compressed Jet Nebulizer
  • Breath Actuated Pneumatic Nebulizer
  • Vented Actuated Pneumatic Nebulizer
  • Ultrasound Nebulizer
  • Mesh Nebulizer

By End User

Homecare Settings

  • Out Patient Settings
  • Others
  • Hospitals
  • Clinics
  • Long Term Centers

By Application

  • COPD
  • Cystic Fibrosis
  • Asthma

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Nebulizer Devices Market Overview

3. Market View Point

  • 3.1. Macro factors
  • 3.2. Drivers
  • 3.3. Restraints
  • 3.4. Trends
  • 3.5. Opportunities
  • 3.6. Outlook by Country (North America)
  • 3.7. Outlook by Country (Europe & Asia-Pacific)
  • 3.8. COPD Prevalence in U.S
  • 3.9. Asthma Prevalence in U.S
  • 3.10. Preferences and Insights
  • 3.11. Product Market Scenario
  • 3.12. Product Type Evolution
  • 3.13. Profit Margin and Revenue Analysis
  • 3.14. Manufacturer
  • 3.15. Drug Used for Asthma & COPD
  • 3.16. Reimbursement (North America)
  • 3.17. Rental Product Scenarios (North America)
  • 3.18. Insurances (North America)
  • 3.19. Porter's Five Forces Analysis
  • 3.20. Key Regulation

4. North America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 4.4.1. Compressed Jet Nebulizer
      • 4.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.4.2. Ultrasound Nebulizer
    • 4.4.3. Mesh Nebulizer
  • 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 4.5.1. Compressed Jet Nebulizer
      • 4.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.5.2. Ultrasound Nebulizer
    • 4.5.3. Mesh Nebulizer
  • 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 4.6.1. COPD
    • 4.6.2. Cystic Fibrosis
    • 4.6.3. Asthma
    • 4.6.4. Others
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 4.7.1. COPD
    • 4.7.2. Cystic Fibrosis
    • 4.7.3. Asthma
    • 4.7.4. Others
  • 4.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 4.8.1. Homecare Setting
    • 4.8.2. Out Patient Settings
    • 4.8.3. Others
      • 4.8.3.1. Hospitals
      • 4.8.3.2. Clinics
      • 4.8.3.3. Long Term Centers
  • 4.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 4.9.1. Homecare Setting
    • 4.9.2. Out Patient Settings
    • 4.9.3. Others
      • 4.9.3.1. Hospitals
      • 4.9.3.2. Clinics
      • 4.9.3.3. Long Term Centers
  • 4.10. Market Attractiveness Analysis
    • 4.10.1. By Country
    • 4.10.2. By Product Type
    • 4.10.3. By Application
    • 4.10.4. By End User
  • 4.11. Key Representative Market Participants
  • 4.12. Key Participants Market Presence (Intensity Map)

5. Latin America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 5.4.1. Compressed Jet Nebulizer
      • 5.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.4.2. Ultrasound Nebulizer
    • 5.4.3. Mesh Nebulizer
  • 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 5.5.1. Compressed Jet Nebulizer
      • 5.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.5.2. Ultrasound Nebulizer
    • 5.5.3. Mesh Nebulizer
  • 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 5.6.1. COPD
    • 5.6.2. Cystic Fibrosis
    • 5.6.3. Asthma
    • 5.6.4. Others
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 5.7.1. COPD
    • 5.7.2. Cystic Fibrosis
    • 5.7.3. Asthma
    • 5.7.4. Others
  • 5.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 5.8.1. Homecare Setting
    • 5.8.2. Out Patient Settings
    • 5.8.3. Others
      • 5.8.3.1. Hospitals
      • 5.8.3.2. Clinics
      • 5.8.3.3. Long Term Centers
  • 5.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 5.9.1. Homecare Setting
    • 5.9.2. Out Patient Settings
    • 5.9.3. Others
      • 5.9.3.1. Hospitals
      • 5.9.3.2. Clinics
      • 5.9.3.3. Long Term Centers
  • 5.10. Market Attractiveness Analysis
    • 5.10.1. By Country
    • 5.10.2. By Product Type
    • 5.10.3. By Application
    • 5.10.4. By End User
  • 5.11. Key Representative Market Participants
  • 5.12. Key Participants Market Presence (Intensity Map)

6. Western Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K
    • 6.2.3. France
    • 6.2.4. Spain
    • 6.2.5. Italy
    • 6.2.6. Nordic Countries
    • 6.2.7. Rest of Western Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Nordic Countries
    • 6.3.7. Rest of Western Europe
  • 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 6.4.1. Compressed Jet Nebulizer
      • 6.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.4.2. Ultrasound Nebulizer
    • 6.4.3. Mesh Nebulizer
  • 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 6.5.1. Compressed Jet Nebulizer
      • 6.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.5.2. Ultrasound Nebulizer
    • 6.5.3. Mesh Nebulizer
  • 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 6.6.1. COPD
    • 6.6.2. Cystic Fibrosis
    • 6.6.3. Asthma
    • 6.6.4. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 6.7.1. COPD
    • 6.7.2. Cystic Fibrosis
    • 6.7.3. Asthma
    • 6.7.4. Others
  • 6.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 6.8.1. Homecare Setting
    • 6.8.2. Out Patient Settings
    • 6.8.3. Others
      • 6.8.3.1. Hospitals
      • 6.8.3.2. Clinics
      • 6.8.3.3. Long Term Centers
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 6.9.1. Homecare Setting
    • 6.9.2. Out Patient Settings
    • 6.9.3. Others
      • 6.9.3.1. Hospitals
      • 6.9.3.2. Clinics
      • 6.9.3.3. Long Term Centers
  • 6.10. Market Attractiveness Analysis
    • 6.10.1. By Country
    • 6.10.2. By Product Type
    • 6.10.3. By Application
    • 6.10.4. By End User
  • 6.11. Key Representative Market Participants
  • 6.12. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 7.2.1. Russia
    • 7.2.2. Poland
    • 7.2.3. Rest of Eastern Europe
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 7.3.1. Russia
    • 7.3.2. Poland
    • 7.3.3. Rest of Eastern Europe
  • 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 7.4.1. Compressed Jet Nebulizer
      • 7.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.4.2. Ultrasound Nebulizer
    • 7.4.3. Mesh Nebulizer
  • 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 7.5.1. Compressed Jet Nebulizer
      • 7.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.5.2. Ultrasound Nebulizer
    • 7.5.3. Mesh Nebulizer
  • 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 7.6.1. COPD
    • 7.6.2. Cystic Fibrosis
    • 7.6.3. Asthma
    • 7.6.4. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 7.7.1. COPD
    • 7.7.2. Cystic Fibrosis
    • 7.7.3. Asthma
    • 7.7.4. Others
  • 7.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 7.8.1. Homecare Setting
    • 7.8.2. Out Patient Settings
    • 7.8.3. Others
      • 7.8.3.1. Hospitals
      • 7.8.3.2. Clinics
      • 7.8.3.3. Long Term Centers
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 7.9.1. Homecare Setting
    • 7.9.2. Out Patient Settings
    • 7.9.3. Others
      • 7.9.3.1. Hospitals
      • 7.9.3.2. Clinics
      • 7.9.3.3. Long Term Centers
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Product Type
    • 7.10.3. By Application
    • 7.10.4. By End User
  • 7.11. Key Representative Market Participants
  • 7.12. Key Participants Market Presence (Intensity Map)

8. APEJ Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Australia & NZ
    • 8.2.4. ASEAN
    • 8.2.5. Rest of APEJ
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Australia & NZ
    • 8.3.4. ASEAN
    • 8.3.5. Rest of APEJ
  • 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 8.4.1. Compressed Jet Nebulizer
      • 8.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.4.2. Ultrasound Nebulizer
    • 8.4.3. Mesh Nebulizer
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 8.5.1. Compressed Jet Nebulizer
      • 8.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.5.2. Ultrasound Nebulizer
    • 8.5.3. Mesh Nebulizer
  • 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 8.6.1. COPD
    • 8.6.2. Cystic Fibrosis
    • 8.6.3. Asthma
    • 8.6.4. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 8.7.1. COPD
    • 8.7.2. Cystic Fibrosis
    • 8.7.3. Asthma
    • 8.7.4. Others
  • 8.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 8.8.1. Homecare Setting
    • 8.8.2. Out Patient Settings
    • 8.8.3. Others
      • 8.8.3.1. Hospitals
      • 8.8.3.2. Clinics
      • 8.8.3.3. Long Term Centers
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 8.9.1. Homecare Setting
    • 8.9.2. Out Patient Settings
    • 8.9.3. Others
      • 8.9.3.1. Hospitals
      • 8.9.3.2. Clinics
      • 8.9.3.3. Long Term Centers
  • 8.10. Market Attractiveness Analysis
    • 8.10.1. By Country
    • 8.10.2. By Product Type
    • 8.10.3. By Application
    • 8.10.4. By End User
  • 8.11. Key Representative Market Participants
  • 8.12. Key Participants Market Presence (Intensity Map)

9. Japan Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 9.2.1. Compressed Jet Nebulizer
      • 9.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.2.2. Ultrasound Nebulizer
    • 9.2.3. Mesh Nebulizer
  • 9.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 9.3.1. Compressed Jet Nebulizer
      • 9.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.3.2. Ultrasound Nebulizer
    • 9.3.3. Mesh Nebulizer
  • 9.4. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 9.4.1. COPD
    • 9.4.2. Cystic Fibrosis
    • 9.4.3. Asthma
    • 9.4.4. Others
  • 9.5. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 9.5.1. COPD
    • 9.5.2. Cystic Fibrosis
    • 9.5.3. Asthma
    • 9.5.4. Others
  • 9.6. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 9.6.1. Homecare Setting
    • 9.6.2. Out Patient Settings
    • 9.6.3. Others
      • 9.6.3.1. Hospitals
      • 9.6.3.2. Clinics
      • 9.6.3.3. Long Term Centers
  • 9.7. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 9.7.1. Homecare Setting
    • 9.7.2. Out Patient Settings
    • 9.7.3. Others
      • 9.7.3.1. Hospitals
      • 9.7.3.2. Clinics
      • 9.7.3.3. Long Term Centers
  • 9.8. Market Attractiveness Analysis
    • 9.8.1. By Product Type
    • 9.8.2. By Application
    • 9.8.3. By End User
  • 9.9. Key Representative Market Participants
  • 9.10. Key Participants Market Presence (Intensity Map)

10. MEA Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 10.1.Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 10.2.1. GCC Countries
    • 10.2.2. South Africa
    • 10.2.3. Rest of MEA
  • 10.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Rest of MEA
  • 10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 10.4.1. Compressed Jet Nebulizer
      • 10.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.4.2. Ultrasound Nebulizer
    • 10.4.3. Mesh Nebulizer
  • 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 10.5.1. Compressed Jet Nebulizer
      • 10.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.5.2. Ultrasound Nebulizer
    • 10.5.3. Mesh Nebulizer
  • 10.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 10.6.1. COPD
    • 10.6.2. Cystic Fibrosis
    • 10.6.3. Asthma
    • 10.6.4. Others
  • 10.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 10.7.1. COPD
    • 10.7.2. Cystic Fibrosis
    • 10.7.3. Asthma
    • 10.7.4. Others
  • 10.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 10.8.1. Homecare Setting
    • 10.8.2. Out Patient Settings
    • 10.8.3. Others
      • 10.8.3.1. Hospitals
      • 10.8.3.2. Clinics
      • 10.8.3.3. Long Term Centers
  • 10.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 10.9.1. Homecare Setting
    • 10.9.2. Out Patient Settings
    • 10.9.3. Others
      • 10.9.3.1. Hospitals
      • 10.9.3.2. Clinics
      • 10.9.3.3. Long Term Centers
  • 10.10. Market Attractiveness Analysis
    • 10.10.1. By Country
    • 10.10.2. By Product Type
    • 10.10.3. By Application
    • 10.10.4. By End User
  • 10.11. Key Representative Market Participants
  • 10.12. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. Agilent Technologies, Inc.
    • 13.2.2. Allied Healthcare Products, Inc.
    • 13.2.3. CareFusion Corporation (sub. Becton, Dickinson and Company)
    • 13.2.4. Covidien plc (sub. Medtronic)
    • 13.2.5. GE Healthcare
    • 13.2.6. GF Health Products Inc.
    • 13.2.7. Omron Healthcare, Inc.
    • 13.2.8. PARI GmbH
    • 13.2.9. Koninklijke Philips N.V.

14. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
    • 14.2.1. North America
    • 14.2.2. Latin America
    • 14.2.3. Western Europe
    • 14.2.4. Eastern Europe
    • 14.2.5. APEJ
    • 14.2.6. Japan
    • 14.2.7. MEA
  • 14.3. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Western Europe
    • 14.3.4. Eastern Europe
    • 14.3.5. APEJ
    • 14.3.6. Japan
    • 14.3.7. MEA
  • 14.4. Market Attractiveness Analysis By Region

15. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 15.2.1. Compressed Jet Nebulizer
      • 15.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.2.2. Ultrasound Nebulizer
    • 15.2.3. Mesh Nebulizer
  • 15.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 15.3.1. Compressed Jet Nebulizer
      • 15.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.3.2. Ultrasound Nebulizer
    • 15.3.3. Mesh Nebulizer
  • 15.4. Market Attractiveness Analysis By Product Type

16. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 16.2.1. COPD
    • 16.2.2. Cystic Fibrosis
    • 16.2.3. Asthma
    • 16.2.4. Others
  • 16.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 16.3.1. COPD
    • 16.3.2. Cystic Fibrosis
    • 16.3.3. Asthma
    • 16.3.4. Others
  • 16.4. Market Attractiveness Analysis By Application

17. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 17.2.1. Homecare Setting
    • 17.2.2. Out Patient Settings
    • 17.2.3. Others
      • 17.2.3.1. Hospitals
      • 17.2.3.2. Clinics
      • 17.2.3.3. Long Term Centers
  • 17.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 17.3.1. Homecare Setting
    • 17.3.2. Out Patient Settings
    • 17.3.3. Others
      • 17.3.3.1. Hospitals
      • 17.3.3.2. Clinics
    • 17.3.4. Long Term Centers
  • 17.4. Market Attractiveness Analysis By End User

18. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 18.1.Market Size and Y-o-Y Growth
  • 18.2. Absolute $ Opportunity

19. Research Methodology